Yu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yu Zhang has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Jun Luo
Nanjing University of Science and Technology
11 shared publications Chunyuan Hou
School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing, 210094, China
7 shared publicationsJun Wan
School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing, 210094, China
5 shared publicationsZiyao Zhao
School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing, 210094, China
5 shared publicationsJun Gu
School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing, 210094, China
4 shared publicationsPeicheng Wang
School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing, 210094, China
4 shared publications
Latest Publications
- Open Access
- 9 February 2026
- Published by Springer Nature in Research Square
A sonopiezoresponse COF-based smart nanoreactor orchestrating in situ bioorthogonal chemistry and cuproptosis for enhanced tumor piezocatalytic therapy
Piezocatalytic therapy (PCT) has garnered increasing interest in the field of cancer treatment. However, its therapeutic efficacy is hampered by the limitations of current piezoelectric materials and the intrinsic therapeutic resistance of tumors. Here, leveraging elaborately designed copper-coordinated covalent organic frameworks (CuCOF-2N) as novel piezocatalysts, a smart ultrasound-controlled nanoreactor (Cu2N@D-FA) is constructed by co-encapsulating with doxorubicin prodrug into folic acid-modified liposomes, to enhance the antitumor efficacy of PCT through the combination of cuproptosis and bioorthogonal catalysis. The structure-property comparison with related COFs underscores the important role of highly polar triazine rings and symmetry-disrupting bidentate ligands in enhancing piezoelectric performance of CuCOF-2N. Upon ultrasound irradiation, CuCOF-2N not only produces hydroxyl radicals independently of oxygen but also enables a self-sustained oxygen supply for generating superoxide anions and singlet oxygen, which surmount constraints of traditional piezoelectric materials to trigger strong PCT. Moreover, the mediated-copper valence switching in CuCOF-2N permits spatiotemporally precise bioorthogonal catalysis and triggers cuproptosis, overcoming therapeutic limitations and amplifying the PCT effect. In vivo studies demonstrate that Cu2N@D-FA selectively accumulates in the tumor and effectively eliminates the tumor without side-effects under US stimulation. Therefore, this study highlights the great promise of COFs in piezocatalysis and offers novel insights for enhancing PCT.
- 9 February 2026
- Published by Springer Nature in Research Square
Open AccessA sonopiezoresponse COF-based smart nanoreactor orchestrating in situ bioorthogonal chemistry and cuproptosis for enhanced tumor piezocatalytic therapy
Piezocatalytic therapy (PCT) has garnered increasing interest in the field of cancer treatment. However, its therapeutic efficacy is hampered by the limitations of current piezoelectric materials and the intrinsic therapeutic resistance of tumors. Here, leveraging elaborately designed copper-coordinated covalent organic frameworks (CuCOF-2N) as novel piezocatalysts, a smart ultrasound-controlled nanoreactor (Cu2N@D-FA) is constructed by co-encapsulating with doxorubicin prodrug into folic acid-modified liposomes, to enhance the antitumor efficacy of PCT through the combination of cuproptosis and bioorthogonal catalysis. The structure-property comparison with related COFs underscores the important role of highly polar triazine rings and symmetry-disrupting bidentate ligands in enhancing piezoelectric performance of CuCOF-2N. Upon ultrasound irradiation, CuCOF-2N not only produces hydroxyl radicals independently of oxygen but also enables a self-sustained oxygen supply for generating superoxide anions and singlet oxygen, which surmount constraints of traditional piezoelectric materials to trigger strong PCT. Moreover, the mediated-copper valence switching in CuCOF-2N permits spatiotemporally precise bioorthogonal catalysis and triggers cuproptosis, overcoming therapeutic limitations and amplifying the PCT effect. In vivo studies demonstrate that Cu2N@D-FA selectively accumulates in the tumor and effectively eliminates the tumor without side-effects under US stimulation. Therefore, this study highlights the great promise of COFs in piezocatalysis and offers novel insights for enhancing PCT.
- 4 February 2026
- Published by Springer Nature in Science China Materials
- Vol. 69 (5) , 2953-2964
A dual enzyme-mimicking COF sonosensitizer potentiates cancer sonodynamic therapy via cascade oxygenation and ROS storm
- 4 February 2026
- Published by Springer Nature in Science China Materials
- Vol. 69 (5) , 2953-2964
A dual enzyme-mimicking COF sonosensitizer potentiates cancer sonodynamic therapy via cascade oxygenation and ROS storm
- 28 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (1) , 411-421
Peripheral tailoring of pentacene: developing next-generation organic sonosensitizers for cancer sonodynamic therapy
Through peripheral modification of the pentacene core, two derivatives were synthesized. Subsequent in vitro cellular assays and in vivo sonodynamic therapy evaluations demonstrated their great potential as promising sonosensitizers.
- 28 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (1) , 411-421
Peripheral tailoring of pentacene: developing next-generation organic sonosensitizers for cancer sonodynamic therapy
Through peripheral modification of the pentacene core, two derivatives were synthesized. Subsequent in vitro cellular assays and in vivo sonodynamic therapy evaluations demonstrated their great potential as promising sonosensitizers.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (27) , 14543-14552
Selective N -demethylation of aryl tertiary amines via a photoinduced COF catalytic strategy
Herein, we have developed a fully conjugated donor–acceptor COF as a heterogeneous photocatalyst for the photoinduced N -demethylation of N , N -dimethylaminophenyl derivatives, with broad substrate scope, high yields, and facile gram-scale scalability.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (27) , 14543-14552
Selective N -demethylation of aryl tertiary amines via a photoinduced COF catalytic strategy
Herein, we have developed a fully conjugated donor–acceptor COF as a heterogeneous photocatalyst for the photoinduced N -demethylation of N , N -dimethylaminophenyl derivatives, with broad substrate scope, high yields, and facile gram-scale scalability.
- 12 December 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (3) , 1127-1134
Enhancing the anticancer efficacy of a nitric oxide and formaldehyde co-donor through isotope substitution
Isotope-substituted co-donors of NO and FA slow metabolism and prolong circulation. Their liposomal formulations enhance tumor suppression with minimal toxicity, demonstrating isotope editing combined with nanodelivery can optimize gasotherapy.
- 12 December 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (3) , 1127-1134
Enhancing the anticancer efficacy of a nitric oxide and formaldehyde co-donor through isotope substitution
Isotope-substituted co-donors of NO and FA slow metabolism and prolong circulation. Their liposomal formulations enhance tumor suppression with minimal toxicity, demonstrating isotope editing combined with nanodelivery can optimize gasotherapy.
- Open Access
- 21 July 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (34) , 15587-15596
Impact of stereochemistry in 3D energetic materials science: a case based on peripheral editing of the 2,4,10-trioxaadamantane backbone
Two series of energetic stereoisomers were synthesized via peripheral editing strategy. The differences in density and detonation performance indicate that stereochemistry holds promise as an effective strategy for designing and synthesizing HEDMs.
- 21 July 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (34) , 15587-15596
Open AccessImpact of stereochemistry in 3D energetic materials science: a case based on peripheral editing of the 2,4,10-trioxaadamantane backbone
Two series of energetic stereoisomers were synthesized via peripheral editing strategy. The differences in density and detonation performance indicate that stereochemistry holds promise as an effective strategy for designing and synthesizing HEDMs.
- 14 May 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 13 (26) , 20562-20567
An efficient synthetic method for cage-like energetic frameworks with high energy density and appropriate oxygen balance
Organic cage-like 3D frameworks can serve as crucial skeletal structures for the development of prospective energetic materials owing to their high inherent density, symmetrical structure, and flexible design. Herein, we present an efficient synthesis method for all-bridge carbon-substituted polynitroheteroadamantanes and their structural isomers for the first time. A series of novel energetic compounds (1–5) containing five or six explosophoric groups with four distinct frameworks (adamantane, proadamantane, homonoradamantane and twistane) was synthesized. All the five compounds exhibited high density (ρ > 1.85 g cm−3) and excellent detonation performance (D > 8500 m s−1, P > 34 GPa). In addition, they all possessed reasonable oxygen balance (OBco > 10%), which was superior to that of the classical highly explosive RDX (OBco = 0%). Furthermore, constructing the cage-like frameworks within two synthetic steps represented a significant advancement in the synthesis of cage-like compounds. This efficient synthetic method followed a concise route, exhibited time efficiency and possessed excellent molecule diversity of the raw material. These unique properties showed that cage-like frameworks have potential applications as high energy density materials.
- 14 May 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 13 (26) , 20562-20567
An efficient synthetic method for cage-like energetic frameworks with high energy density and appropriate oxygen balance
Organic cage-like 3D frameworks can serve as crucial skeletal structures for the development of prospective energetic materials owing to their high inherent density, symmetrical structure, and flexible design. Herein, we present an efficient synthesis method for all-bridge carbon-substituted polynitroheteroadamantanes and their structural isomers for the first time. A series of novel energetic compounds (1–5) containing five or six explosophoric groups with four distinct frameworks (adamantane, proadamantane, homonoradamantane and twistane) was synthesized. All the five compounds exhibited high density (ρ > 1.85 g cm−3) and excellent detonation performance (D > 8500 m s−1, P > 34 GPa). In addition, they all possessed reasonable oxygen balance (OBco > 10%), which was superior to that of the classical highly explosive RDX (OBco = 0%). Furthermore, constructing the cage-like frameworks within two synthetic steps represented a significant advancement in the synthesis of cage-like compounds. This efficient synthetic method followed a concise route, exhibited time efficiency and possessed excellent molecule diversity of the raw material. These unique properties showed that cage-like frameworks have potential applications as high energy density materials.
- 3 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (27) , 5174-5177
2,9-Diaryl-6,13-bis(triisopropylsilylethynyl)pentacene derivatives: synthesis and application in cancer sonodynamic therapy
Four 2,6,9,13-functionalized pentacene derivatives were synthesized and used for sonodynamic therapy. In vitro and in vivo therapeutic results showed that these compounds could with ultrasound eliminate cancer cells.
- 3 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (27) , 5174-5177
2,9-Diaryl-6,13-bis(triisopropylsilylethynyl)pentacene derivatives: synthesis and application in cancer sonodynamic therapy
Four 2,6,9,13-functionalized pentacene derivatives were synthesized and used for sonodynamic therapy. In vitro and in vivo therapeutic results showed that these compounds could with ultrasound eliminate cancer cells.
- Open Access
- 30 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (35) , eadn8695
A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment
Despite the therapeutic benefits of insulin-pramlintide dual-hormone therapy in diabetes, its application potential has been limited due to a lack of efficient delivery routes. Here, we developed a temperature-responsive dual-hormone foam nanoengine (HormFoam) and combined it with a customized spraying device to further construct an in situ foam-generating system for improving the rectal bioavailability of dual-hormone therapy. To support rapid clinical translation, a continuous microfluidic preparation for HormFoam was proposed, including the power unit of perfluorocarbon nanodroplets and the pharmaceutical components Pluronic F127–functionalized liposomal insulin and pramlintide. We found that HormFoam could consistently generate foams to drive drugs forward after rectal administration, which enhanced intestinal distribution and mucosa absorption, leading to systemic codelivery of insulin-pramlintide. HormFoam reproduced the physiology of endocrine pancreas for glycemic control and induced body weight loss while reversing metabolic disorders in diabetic mice with good biosafety. Therefore, HormFoam represents a state-of-the-art dual-hormone regimen with the potential to address unmet needs in diabetes management.
- 30 August 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (35) , eadn8695
Open AccessA temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment
Despite the therapeutic benefits of insulin-pramlintide dual-hormone therapy in diabetes, its application potential has been limited due to a lack of efficient delivery routes. Here, we developed a temperature-responsive dual-hormone foam nanoengine (HormFoam) and combined it with a customized spraying device to further construct an in situ foam-generating system for improving the rectal bioavailability of dual-hormone therapy. To support rapid clinical translation, a continuous microfluidic preparation for HormFoam was proposed, including the power unit of perfluorocarbon nanodroplets and the pharmaceutical components Pluronic F127–functionalized liposomal insulin and pramlintide. We found that HormFoam could consistently generate foams to drive drugs forward after rectal administration, which enhanced intestinal distribution and mucosa absorption, leading to systemic codelivery of insulin-pramlintide. HormFoam reproduced the physiology of endocrine pancreas for glycemic control and induced body weight loss while reversing metabolic disorders in diabetic mice with good biosafety. Therefore, HormFoam represents a state-of-the-art dual-hormone regimen with the potential to address unmet needs in diabetes management.